A Multi-Cohort Study of Polymorphisms in the GH/IGF Axis and Physical Capability: The HALCyon Programme

Background Low muscle mass and function have been associated with poorer indicators of physical capability in older people, which are in-turn associated with increased mortality rates. The growth hormone/insulin-like growth factor (GH/IGF) axis is involved in muscle function and genetic variants in genes in the axis may influence measures of physical capability. Methods As part of the Healthy Ageing across the Life Course (HALCyon) programme, men and women from seven UK cohorts aged between 52 and 90 years old were genotyped for six polymorphisms: rs35767 (IGF1), rs7127900 (IGF2), rs2854744 (IGFBP3), rs2943641 (IRS1), rs2665802 (GH1) and the exon-3 deletion of GHR. The polymorphisms have previously been robustly associated with age-related traits or are potentially functional. Meta-analysis was used to pool within-study genotypic effects of the associations between the polymorphisms and four measures of physical capability: grip strength, timed walk or get up and go, chair rises and standing balance. Results Few important associations were observed among the several tests. We found evidence that rs2665802 in GH1 was associated with inability to balance for 5 s (pooled odds ratio per minor allele = 0.90, 95% CI: 0.82–0.98, p-value = 0.01, n = 10,748), after adjusting for age and sex. We found no evidence for other associations between the polymorphisms and physical capability traits. Conclusion Our findings do not provide evidence for a substantial influence of these common polymorphisms in the GH/IGF axis on objectively measured physical capability levels in older adults.

[1]  M. D. de Wit,et al.  Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions , 2012, Annals of the rheumatic diseases.

[2]  C. Gieger,et al.  A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3. , 2011, Human molecular genetics.

[3]  A. Yashin,et al.  Heritability estimates of endophenotypes of long and health life: the Long Life Family Study. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[4]  Rebecca Hardy,et al.  Objective measures of physical capability and subsequent health: a systematic review , 2010, Age and ageing.

[5]  D. Kuh,et al.  Objectively measured physical capability levels and mortality: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[6]  Ayellet V. Segrè,et al.  Hundreds of variants clustered in genomic loci and biological pathways affect human height , 2010, Nature.

[7]  Jing Hua Zhao,et al.  Physical Activity Attenuates the Genetic Predisposition to Obesity in 20,000 Men and Women from EPIC-Norfolk Prospective Population Study , 2010, PLoS medicine.

[8]  W. Willett,et al.  A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. , 2010, Human molecular genetics.

[9]  D. Cooper,et al.  Characterisation of a functional intronic polymorphism in the human growth hormone (GHI) gene , 2010, Human Genomics.

[10]  Y. Kamatani,et al.  A genome-wide association study in 19 633 Japanese subjects identified LHX3-QSOX2 and IGF1 as adult height loci. , 2010, Human molecular genetics.

[11]  E. Hoffman,et al.  A polymorphism near IGF1 is associated with body composition and muscle function in women from the Health, Aging, and Body Composition Study , 2010, European Journal of Applied Physiology.

[12]  P. Delmas,et al.  Rapid loss of appendicular skeletal muscle mass is associated with higher all-cause mortality in older men: the prospective MINOS study. , 2010, The American journal of clinical nutrition.

[13]  P. Visscher,et al.  Common variants of large effect in F12, KNG1, and HRG are associated with activated partial thromboplastin time. , 2010, American journal of human genetics.

[14]  S. Land,et al.  Chromosome 5p Region SNPs Are Associated with Risk of NSCLC among Women , 2010, Journal of cancer epidemiology.

[15]  R. Riley,et al.  Meta-analysis of individual participant data: rationale, conduct, and reporting , 2010, BMJ : British Medical Journal.

[16]  C. Cooper,et al.  Cohort profile: The Hertfordshire Ageing Study (HAS). , 2010, International journal of epidemiology.

[17]  Christian Gieger,et al.  New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk , 2010, Nature Genetics.

[18]  Jean Tichet,et al.  Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia , 2009, Nature Genetics.

[19]  M. Pirmohamed,et al.  The d3/fl-GH receptor gene polymorphism does not influence quality of life and body composition in GH-deficient adults receiving GH replacement therapy. , 2009, European journal of endocrinology.

[20]  Ali Amin Al Olama,et al.  Identification of seven new prostate cancer susceptibility loci through a genome-wide association study , 2009, Nature Genetics.

[21]  P. Cawthon,et al.  Sarcopenia: etiology, clinical consequences, intervention, and assessment , 2009, Osteoporosis International.

[22]  D. Clemmons.  Role of IGF-I in skeletal muscle mass maintenance , 2009, Trends in Endocrinology & Metabolism.

[23]  Hongbing Shen,et al.  Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies , 2009, European Journal of Human Genetics.

[24]  J. Ioannidis,et al.  Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. , 2009, Journal of clinical epidemiology.

[25]  S. Levy,et al.  Genome-wide association and replication studies identified TRHR as an important gene for lean body mass. , 2009, American journal of human genetics.

[26]  R. Baserga.  The insulin receptor substrate-1: a biomarker for cancer? , 2009, Experimental cell research.

[27]  J. Kopchick,et al.  Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models. , 2008, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[28]  S. Gruber,et al.  Recreational Physical Activity Modifies the Association Between a Common GH1 Polymorphism and Colorectal Cancer Risk , 2008, Cancer Epidemiology Biomarkers & Prevention.

[29]  R. Recker,et al.  Comprehensive association analyses of IGF1, ESR2, and CYP17 genes with adult height in Caucasians , 2008, European Journal of Human Genetics.

[30]  S. Giovannini,et al.  Modulation of GH/IGF-1 axis: Potential strategies to counteract sarcopenia in older adults , 2008, Mechanisms of Ageing and Development.

[31]  M. Pike,et al.  IGF-1, IGFBP-1, and IGFBP-3 Polymorphisms Predict Circulating IGF Levels but Not Breast Cancer Risk: Findings from the Breast and Prostate Cancer Cohort Consortium (BPC3) , 2008, PloS one.

[32]  K. Lunetta.  Genetic Association Studies , 2008, Circulation.

[33]  C. Velloso.  Regulation of muscle mass by growth hormone and IGF‐I , 2008, British journal of pharmacology.

[34]  A. Ashworth,et al.  Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy. , 2008, Human molecular genetics.

[35]  D. Melzer,et al.  Epidemiology of balance and dizziness in a national population: findings from the English Longitudinal Study of Ageing. , 2008, Age and ageing.

[36]  J. Thompson,et al.  How should we use information about HWE in the meta-analyses of genetic association studies? , 2008, International journal of epidemiology.

[37]  James M Hagberg,et al.  Influence of promoter region variants of insulin-like growth factor pathway genes on the strength-training response of muscle phenotypes in older adults. , 2007, Journal of applied physiology.

[38]  M. Sandhu,et al.  Study of association between common variation in the insulin-like growth factor 2 gene and indices of obesity and body size in middle-aged men and women. , 2007, The Journal of clinical endocrinology and metabolism.

[39]  J. Hirschhorn,et al.  Common genetic variation in eight genes of the GH/IGF1 axis does not contribute to adult height variation , 2007, Human Genetics.

[40]  James Strait,et al.  Genome-Wide Association Scan Shows Genetic Variants in the FTO Gene Are Associated with Obesity-Related Traits , 2007, PLoS genetics.

[41]  E. Hoffman,et al.  IGF-II gene region polymorphisms related to exertional muscle damage. , 2007, Journal of applied physiology.

[42]  D. Cole,et al.  Relationship of the human growth hormone receptor exon 3 genotype with final adult height and bone mineral density. , 2007, The Journal of clinical endocrinology and metabolism.

[43]  H. Grönberg,et al.  Haplotype-Based Analysis of Common Variation in the Growth Hormone Receptor Gene and Prostate Cancer Risk , 2007, Cancer Epidemiology Biomarkers & Prevention.

[44]  Tom R. Gaunt,et al.  Refined Association Mapping for a Quantitative Trait: Weight in the H19‐IGF2‐INS‐TH Region , 2006, Annals of human genetics.

[45]  P. Kelly,et al.  Growth hormone promotes skeletal muscle cell fusion independent of insulin-like growth factor 1 up-regulation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[46]  D. Kuh,et al.  Cohort Profile: The 1946 National Birth Cohort (MRC National Survey of Health and Development). , 2006, International journal of epidemiology.

[47]  T. Noakes,et al.  Growth hormone 1 (GH1) gene and performance and post-race rectal temperature during the South African Ironman triathlon , 2006, British Journal of Sports Medicine.

[48]  I. Janssen.  Influence of Sarcopenia on the Development of Physical Disability: The Cardiovascular Health Study , 2006, Journal of the American Geriatrics Society.

[49]  C. Cooper,et al.  Cohort profile: the Hertfordshire cohort study. , 2005, International journal of epidemiology.

[50]  R. Ebstein,et al.  Association between the insulin-like growth factor 2 gene (IGF2) and scores on the Eating Attitudes Test in nonclinical subjects: a family-based study. , 2005, The American journal of psychiatry.

[51]  S. Bandinelli,et al.  Insulin resistance and muscle strength in older persons. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[52]  G. Smith,et al.  Cohort profile: The Boyd Orr cohort--an historical cohort study based on the 65 year follow-up of the Carnegie Survey of Diet and Health (1937-39). , 2005, International journal of epidemiology.

[53]  R. Wolff,et al.  Insulin-Like Growth Factor Pathway Polymorphisms Associated with Body Size in Hispanic and Non-Hispanic White Women , 2005, Cancer Epidemiology Biomarkers & Prevention.

[54]  B. Zwaan,et al.  Reduced insulin/IGF‐1 signalling and human longevity , 2005, Aging cell.

[55]  R. Hardy,et al.  Grip strength, postural control, and functional leg power in a representative cohort of British men and women: associations with physical activity, health status, and socioeconomic conditions. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[56]  R. Ebstein,et al.  Candidate genes associated with ageing and life expectancy in the Jerusalem longitudinal study , 2005, Mechanisms of Ageing and Development.

[57]  M. Päivänsalo,et al.  IGF‐I concentrations are positively associated with carotid artery atherosclerosis in women , 2005, Annals of medicine.

[58]  P. Delmas,et al.  Low Skeletal Muscle Mass Is Associated With Poor Structural Parameters of Bone and Impaired Balance in Elderly Men—The MINOS Study , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[59]  E. Metter,et al.  Insulin-like growth factor-2 genotype, fat-free mass, and muscle performance across the adult life span. , 2004, Journal of applied physiology.

[60]  X. Shu,et al.  Genetic polymorphisms in the human growth hormone‐1 gene (GH1) and the risk of breast carcinoma , 2004, Cancer.

[61]  Luigi Ferrucci,et al.  Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. , 2003, Journal of applied physiology.

[62]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[63]  C. Cooper,et al.  Polymorphism of the IGF2 gene, birth weight and grip strength in adult men. , 2002, Age and ageing.

[64]  L. Le Marchand,et al.  Association of a common polymorphism in the human GH1 gene with colorectal neoplasia. , 2002, Journal of the National Cancer Institute.

[65]  Tom R. Gaunt,et al.  Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males. , 2001, Human molecular genetics.

[66]  R. Dennis Cook,et al.  Detection of Influential Observation in Linear Regression , 2000, Technometrics.

[67]  S. Heymsfield,et al.  Epidemiology of sarcopenia among the elderly in New Mexico. , 1998, American journal of epidemiology.

[68]  R B Wallace,et al.  Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. , 1995, The New England journal of medicine.

[69]  Diane Podsiadlo,et al.  The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons , 1991, Journal of the American Geriatrics Society.

[70]  P. Bougnères.  The exon-3 deletion of the growth hormone receptor (GHR) gene still has a limited impact in clinical endocrinology. , 2010, The Journal of clinical endocrinology and metabolism.

[71]  B. Han,et al.  Identification of 15 loci influencing height in a Korean population , 2010, Journal of Human Genetics.

[72]  Christian Gieger,et al.  Six new loci associated with body mass index highlight a neuronal influence on body weight regulation , 2009, Nature Genetics.

[73]  G. Abellán van Kan.  Epidemiology and consequences of sarcopenia , 2009, The journal of nutrition, health & aging.

[74]  Wj Gauderman,et al.  QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies , 2006 .

[75]  Tom R. Gaunt,et al.  Experience applying light typerTM methodology to human SNPs relevant to growth and cardiovascular risk , 2006 .

[76]  M. Rudnicki,et al.  Cellular and molecular regulation of muscle regeneration. , 2004, Physiological reviews.

[77]  J. Kaprio,et al.  Heritability of maximal isometric muscle strength in older female twins. , 2004, Journal of applied physiology.

[78]  Ian J Deary,et al.  The impact of childhood intelligence on later life: following up the Scottish mental surveys of 1932 and 1947. , 2004, Journal of personality and social psychology.

[79]  J. Nazroo.  Health, wealth and lifestyles of the older population in England: The 2002 English Longitudinal Study of Ageing , 2003 .

[80]  Ack,et al.  LOWER-EXTREMITY FUNCTION IN PERSONS OVER THE AGE OF 70 YEARS AS A PREDICTOR OF SUBSEQUENT DISABILITY , 2001 .

[81]  Obert,et al.  Effects of human growth hormone in men over 60 years old. , 1990, The New England journal of medicine.

[82]  D. Mccarty,et al.  Simple method for measurement of lower extremity muscle strength. , 1985, The American journal of medicine.

[83]  A. Bartke.  Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/en.2005-0411 Minireview: Role of the Growth Hormone/Insulin-Like Growth Factor System in Mammalian Aging , 2022 .